Clinical Trial Update: Holmium-166 TARE in Liver Limited Unresectable Colorectal Cancer Patients [Phase 2]

View source ↗

Summary

This update notes the termination of a Phase 2 trial evaluating Holmium-166 transarterial radioembolization for liver-limited unresectable colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Holmium-166 transarterial radioembolization

Snippet

Sponsor: Gruppo Oncologico del Nord-Ovest | Conditions: Colorectal Cancer Metastatic | Phase 2 | Status: TERMINATED